Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
Sign in
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Sign in
Mogrify to present preclini...
MetaVia shows uric acid red...
Annovis secures patent for ...
Eisai, Linus Health launch ...
Alzheon launches second Pha...
Mogrify to present preclini...
MetaVia shows uric acid red...
Annovis secures patent for ...
Eisai, Linus Health launch ...
Alzheon launches second Pha...
Biophytis
AI/Digital
Biotech
Biophytis-LynxKite AI alliance broadens longevity drug pipeline
Biotech
Biophytis launches trial targeting muscle loss in GLP-1 obesity treatment
Investment
Investment
Publicly traded longevity companies announce new finance
Biotech
Investment
Investment
Biophytis applies to commence “first ever” Phase 3 sarcopenia trial
Investment
Investment
Longevity investment bulletin: Longevica, Biophytis, Recursion and more
Investment
Investment
Longevity investment bulletin: Celularity, Biophytis, Longeveron and more
Investment
Investment
Longevity investment bulletin: CBMG, NeuroSense, D&D Pharmatech and more
Investment
Investment
Longevity investment bulletin: PocDoc, AbbVie, Athersys and more
Investment
Investment
Longevity investment bulletin: Insilico Medicine, Biophytis, Synartro and more
Google
Microsoft
Apple
LinkedIn
or use your email
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report